SCM
ICPT

Stevens Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Stevens Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,875
Closed -$1.18M – 1274
2015
Q2 		$1.18M Buy
+4,875
New +$1.3M 0.04% 386
2015
Q1 		– Sell
-2,634
Closed -$411K – 1299
2014
Q4 		$411K Sell
2,634
-14,171
-84% -$2.62M 0.01% 631
2014
Q3 		$3.98M Buy
16,805
+10,772
+179% +$2.75M 0.12% 213
2014
Q2 		$1.43M Buy
+6,033
New +$1.59M 0.04% 429

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Stevens Capital Management's ICPT Position: Q3 2015 in Review

Stevens Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2015, closing a stake of 4,875 shares — an estimated $1.18M sold.

Stevens Capital Management first reported a position in ICPT in Q2 2014 and held it in 4 quarters. The position peaked at $3.98M in Q3 2014. 173 funds tracked by Wall St. Rank hold ICPT as of Q3 2015.

  • Stevens Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Stevens Capital Management sold 4,875 Intercept Pharmaceuticals, Inc. shares in Q3 2015, an estimated $1.18M.
  • Stevens Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 4 quarters.
  • Stevens Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $3.98M in Q3 2014.
  • 173 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2015.

Based on Stevens Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.